Matthew L. Kaplan
Director at Nuvectis Pharma, Inc. (NVCT)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+49.2%
vs. S&P 500+46.5%
Beat the market100%
Paper profit on buys+$168K
Total bought / sold$64K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 6SEC | NVCTNuvectis Pharma, Inc. | Buy | 11,000124,760 held (+10%) | $5.84 | $64K | +261.6% |
- Buy
Director Matthew L. Kaplan bought $64K of NVCT at $5.84 — first open-market purchase in our records.